SDEE has a number of truly fantastic events that range from our monthly happy hours to expert-led workshops and networking events.
Apply for SDEE’s Investor Day with Vida Ventures
Pitch Your Healthcare Startup and Network with Other CEOs/Founders
Submissions due by December 4th, 2018
Arjun Goyal, M.D., Co-founder and Managing Director, Vida Ventures
Vida Ventures is a next-generation life sciences investment firm founded in 2017 by a group of scientists, physicians, entrepreneurs and investors passionate about building and funding breakthroughs in biomedicine. Together they form an independent, bold investment group bound together by a simple word – life. Its mission is to bring science to life and advance transformative biomedical innovations that have the potential to make a meaningful difference for patients. Vida has a bicoastal presence and currently manages approximately $295 million.
To be considered for this event, please submit a single page executive summary, or non-confidential slide deck (less than 25 slides) by December 4th, 2018 via email to: email@example.com
You will be notified by December 11 if your company has been selected for a 1:1 meeting. ALL APPLICANTS are invited and encouraged to attend the networking breakfast and introduction & discussion with Vida Ventures. The event is only open to SDEE Small Business and Corporate members.
(Join here: http://www.sdentrepreneurs.org/join_sdee)
Agenda: 8:00am – 8:30am: Breakfast 8:30am – 9:30pm: Introduction to Vida Ventures and discussion 9:30am – 12:00pm: 1:1 Meetings
Arjun Goyal, M.D., M.Phil, M.B.A
Arjun Goyal is a Co‐Founder and Managing Director of Vida Ventures.
From 2014 through 2017, Arjun was an investment professional at 5AM Ventures, a life science focused venture firm. Arjun was a Board Observer at Aprea AB, Spyryx, Pear Therapeutics, Portal Instruments, Entrada, and Homology Medicines (NASDAQ: FIXX). At 5AM Ventures, Arjun was part of the founding team of Homology Medicines, a genetic medicines company and he also served as Acting VP of Business Development at Pear Therapeutics. Prior to joining 5AM Ventures, Arjun was Co‐Founder and CEO, Foresight Pharmaceuticals, a biopharmaceutical company developing hormonal treatments for infectious diseases.
Arjun received his B.S. in Medical Science, Diploma in French and his M.D. degree from the Universities of Melbourne and Oxford. He completed his postgraduate medical training in Internal Medicine at the University of Sydney. He received his M.Phil. in Bioscience Enterprise from Cambridge on a Commonwealth Scholarship and his MBA from Harvard Business School. Arjun has received several awards for his work including the American Australian Association Education Fellowship, Robert Kaplan Life Science Fellowship, Oxford Clarendon Scholarship, Gates Cambridge Scholarship and Reg Waite Award for Young Australians. He is a co‐inventor on one patent and has served on the editorial board of an international scientific journal.
Arjun is a Board Observer at Pionyr Immunotherapeutics and serves on the Committee for the American Australian Association Education Fellowship and LifeTech Advisory Board of the Swedish American Chamber of Commerce, and was on the 2016 NCI Review Committee for SBIR grants.